Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies - Related scleroderma renal crisis treated with double-filtration plasmapheresis

Internal Medicine

Volumn 36, Issue 7, 1997, Pages 508-513

  Omote, Akiko ^a   Muramatsu, Masahito ^a   Sugimoto, Yoshiyuki ^a   Hosono, Shimako ^a   Murakami, Ryuichiro ^a   Tanaka, Hitoshi ^a   Watanabe, Yoshiaki ^a   Sano, Hiroshi ^a   Kato, Katsumoto ^a  

^a Kamo Hospital   (Japan)

Author keywords

Interstitial pneumonia; Mizoribine (MZR); Necrotizing crescentic glomerulonephritis; Systemic sclerosis (SSc)

Indexed keywords

ANTICOAGULANT AGENT; AUTOANTIBODY; CORTICOSTEROID; DIPYRIDAMOLE; HEPARIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MIZORIBINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; WARFARIN;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FAILURE; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0030739142     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.508     Document Type: Article

References (10)

1. Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis: Review of a 25 year experience with 68 cases. Medicine (Baltimore) 62: 335, 1983.
2. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32: 1128, 1989.
3. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21: 864, 1994.
4. Akimoto S, Ishikawa O, Tamura T, Miyachi Y. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 134: 407, 1996.
5. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113: 352, 1990.
6. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological po tential. Kidney Int 46: 1, 1994.
7. Gelber AC, Wigley FM. Treatment of scleroderma. Curr Opin Rheumatol 7: 551, 1995.
8. Hashimoto H. Steroid pulse therapy for progressive systemic sclerosis. Intern Med 35: 525, 1996.
9. Steen VD, Lanz, JK Jr, Conte C, Owens GR, Medsger TA Jr. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 37: 1290, 1994.
10. Vallance DK, Lynch JP, McCune WJ. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. Curr Opin Rheumatol 7: 174, 1995.